BioCentury
ARTICLE | Clinical News

Avodart dutasteride: Phase IV data

February 6, 2012 8:00 AM UTC

GlaxoSmithKline markets Avodart in over 90 countries to treat symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. Last year, the pharma said it would no longer pursue appr...